Skip to content

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain (VANISH)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06908538
Acronym
VANISH
Enrollment
2000
Registered
2025-04-03
Start date
2025-04-01
Completion date
2035-04-01
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Amputation, Limb Loss, Amputation of Lower Limb, Amputation of Upper Limb, Amputation, Traumatic/Surgery, Cryo Analgesia

Brief summary

The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.

Interventions

DEVICEcryoablation

Cryoanalgesia, also known as Cryoablation, Cryoneurolysis, or Cryonerve Block, has been used for decades to treat chronic pain and has recently been employed for the management of Phantom Limb Pain. Cryoanalgesia involves the use of a probe to apply extreme cold (approximately -70◦C) to induce reversible axonal injury and Wallerian degeneration to produce a temporary conduction block that is sustained until regeneration of the axon and sensation is restored, typically weeks to months later.

Sponsors

AtriCure, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have or will have an amputation procedure; * Patients who are willing and capable of providing informed consent; * Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law.

Exclusion criteria

* Women of childbearing potential who are, or plan to become, pregnant during the time of the study; * Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.

Design outcomes

Primary

MeasureTime frameDescription
Primary Outcome Measure30 daysCryoNerve Block procedural complications

Countries

United States

Contacts

CONTACTSenior Registry Specialist
CryoNB-registry@atricure.com1 (866) 349-2342

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026